Clinical trial
Steroid Free Immunosuppression in Liver Transplantation
NCT00296244 · Thomas Jefferson University, Other · Completed
Key facts
| NCT number | NCT00296244 |
|---|---|
| Title | Steroid Free Immunosuppression in Liver Transplantation |
| Official title | Steroid Free Immunosuppression in Liver Transplantation |
| Lead sponsor | Thomas Jefferson University, Other |
| Collaborators | Novartis Pharmaceuticals Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Liver Cirrhosis, Liver Transplant Disorder |
| Intervention type | Drug |
| Interventions | Steroids, Basiliximab, Tacrolimus, Enteric-coated Mycophenolic acid (EC-MPA) |
| Enrollment | 40 |
| Start date | Feb 1, 2006 |
| Primary completion | May 1, 2008 |
| Completion | Jun 1, 2008 |
| First posted | Feb 24, 2006 |
| Last update posted | Nov 19, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: